noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

OIG - Office of Inspector General

AG's Office Secures Up To $770,000 in Settlements with Former[...]
OIG - Office of Inspector General

Carr: Laboratory Owner Faces Criminal Charges and Civil Complaint for[...]
OIG - Office of Inspector General

Medicaid Fraud Investigations Lead to Conviction, Guilty Plea

Healthcare

Abeona Therapeutics Inc.

06/12/2026 | Press release | Distributed by Public on 06/12/2026 05:30

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 11, 2026, Michael Amoroso resigned as a member of the Board of Directors (the "Board") of Abeona Therapeutics Inc. (the "Company") effective immediately. In connection with his resignation, Mr. Amoroso also resigned from the Nominating and Corporate Governance Committee of the Board on which he served. Mr. Amoroso's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices but solely for personal reasons.

Abeona Therapeutics Inc. published this content on June 12, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 12, 2026 at 11:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]